Skip to content

Treatments for Improving Mood in Depressed Teens-3

Adaptation and Pilot Study of Yoga to Reduce Depression in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03831360
Acronym
TeenThrive
Enrollment
30
Registered
2019-02-05
Start date
2019-10-21
Completion date
2021-09-29
Last updated
2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

Phase 3 is a randomized clinical trial of yoga vs group Cognitive Behavioral Therapy (CBT) for adolescents with depression.

Detailed description

In Phase 3, Study A, the investigators will conduct a pilot Randomized Control Trial (RCT) of 12 weeks of hatha yoga vs. 12 weeks of group CBT. Participants will be adolescents with depression. Parents will also be invited to participate in assessments regarding their child. Study B, which will run concurrent to Phase 3, will be for participants who did not meet the depression inclusion criteria or had recent changes in therapy or medications that make them ineligible for Phase 3. Their data will not be analyzed. They are recruited only for group participation. Participants will be randomized to Phase 3 groups of 12 weeks of hatha yoga or group CBT. Parents will also be invited to participate in assessments regarding their child. \* Due to social distancing requirements related to COVID-19, all interventions have been delivered remotely via video-based platforms as of late March 2020.

Interventions

BEHAVIORALYoga

Hatha yoga for depressed adolescents

BEHAVIORALGroup CBT

Group cognitive behavioral therapy for depressed adolescents

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Butler Hospital
CollaboratorOTHER
Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Please note, inclusion criteria for Phase 3 Study A, and Phase 3 Study B are identical, with the exception that, for Phase 3/ Study B, we will not require elevated depressive symptoms (a) or stable treatment (b). 1. Adolescents must have elevated depressive symptoms, defined by a score of 10 or higher on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS. 2. Other treatment for depression must be stable at baseline. Adolescents do not have to be in other treatment for depression, but, if they are, it must be stable for the past 8 weeks. 3. Adolescents must be aged 13-18. 4. Adolescents must be medically cleared for moderate physical activity by their primary care physician. This criterion may be met by a current (dated in the past year) statement from their pediatrician that the adolescent may participate in school or camp programs including physical education. 5. Adolescents must be able to read and write English sufficient to complete informed consent and engage in interventions. 6. Adolescents aged 13-17 must assent to be in the study, and their parent or legal guardian must consent to their participation. Adolescents aged 18 must consent to be in the study. 7. Able to attend one of the class times.

Design outcomes

Primary

MeasureTime frameDescription
Credibility Expectancy Questionnaire (CEQ) - Credibility SubscaleWeek 1Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are each scored on a range of 0-1, and the mean of thise is used in analyses. Higher scores indicate greater credibility.
Home Practice QuestionnairePost intervention (month 3)Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.
Acceptability12 weeksAcceptability is operationalized by the number of participants who attended 8 or more classes out of possible 12. Target was 70% or greater.
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)Post intervention (month 3)Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.
Credibility Expectancy Questionnaire (CEQ) - Expectancy SubscaleWeek 1Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 and the mean of those scores are analyzed, with higher scores indicating greater expectations.
The Client Satisfaction Questionnaire (CSQ-8)Post intervention (month 3)Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.

Secondary

MeasureTime frameDescription
Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)Baseline to post intervention (month 3)Change in depression symptom severity will be assessed via blind evaluator using the the QIDS. The QIDS is a 17 item measure with scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

Countries

United States

Participant flow

Participants by arm

ArmCount
Hatha Yoga
12 weeks of hatha yoga Yoga: Hatha yoga for depressed adolescents
15
Group CBT
12 weeks of group CBT Group CBT: Group cognitive behavioral therapy for depressed adolescents
15
Total30

Baseline characteristics

CharacteristicHatha YogaTotalGroup CBT
Age, Continuous15.00 years
STANDARD_DEVIATION 1.41
15.00 years
STANDARD_DEVIATION 1.4
15.00 years
STANDARD_DEVIATION 1.46
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants5 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants25 Participants12 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
2 Participants4 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants1 Participants
Race (NIH/OMB)
White
12 Participants23 Participants11 Participants
Region of Enrollment
United States
15 Participants30 Participants15 Participants
Sex: Female, Male
Female
12 Participants25 Participants13 Participants
Sex: Female, Male
Male
3 Participants5 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 15
other
Total, other adverse events
1 / 152 / 15
serious
Total, serious adverse events
0 / 150 / 15

Outcome results

Primary

Acceptability

Acceptability is operationalized by the number of participants who attended 8 or more classes out of possible 12. Target was 70% or greater.

Time frame: 12 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Hatha YogaAcceptability11 Participants
Group CBTAcceptability13 Participants
Primary

Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale

Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are each scored on a range of 0-1, and the mean of thise is used in analyses. Higher scores indicate greater credibility.

Time frame: Week 1

ArmMeasureValue (MEAN)Dispersion
Hatha YogaCredibility Expectancy Questionnaire (CEQ) - Credibility Subscale0.72 score on a scaleStandard Deviation 0.18
Group CBTCredibility Expectancy Questionnaire (CEQ) - Credibility Subscale0.71 score on a scaleStandard Deviation 0.17
Primary

Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale

Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 and the mean of those scores are analyzed, with higher scores indicating greater expectations.

Time frame: Week 1

ArmMeasureValue (MEAN)Dispersion
Hatha YogaCredibility Expectancy Questionnaire (CEQ) - Expectancy Subscale0.57 score on a scaleStandard Deviation 0.2
Group CBTCredibility Expectancy Questionnaire (CEQ) - Expectancy Subscale0.55 score on a scaleStandard Deviation 0.24
Primary

Home Practice Questionnaire

Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.

Time frame: Post intervention (month 3)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Hatha YogaHome Practice Questionnaire3 Participants
Group CBTHome Practice Questionnaire8 Participants
Primary

Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)

Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.

Time frame: Post intervention (month 3)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Hatha YogaSystematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)0 Participants
Group CBTSystematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)0 Participants
Primary

The Client Satisfaction Questionnaire (CSQ-8)

Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.

Time frame: Post intervention (month 3)

ArmMeasureValue (MEAN)Dispersion
Hatha YogaThe Client Satisfaction Questionnaire (CSQ-8)26.8 score on a scaleStandard Deviation 4.18
Group CBTThe Client Satisfaction Questionnaire (CSQ-8)26.1 score on a scaleStandard Deviation 5
Secondary

Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)

Change in depression symptom severity will be assessed via blind evaluator using the the QIDS. The QIDS is a 17 item measure with scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

Time frame: Baseline to post intervention (month 3)

ArmMeasureValue (MEAN)Dispersion
Hatha YogaQuick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)6.92 score on a scaleStandard Deviation 5.2
Group CBTQuick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)8.23 score on a scaleStandard Deviation 3.17

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026